Engele VI, Vassiliou V, Wheelwright S, Sztankay M, Puglisi C, Pogoda K, van Leeuwaarde R, Bleiker E, Abdel-Razeq H, Fox L, Lanceley A, Dabakuyo S, Bjelic-Radisic V, Nordin A, Ioannidis G, Kulís D, Brédart A, Schwaninger G, Arraras JI, Holzner B, Oberguggenberger AS,

Eur J Cancer. 2026 01 9;235:116226

Evaluation of waning of IgG antibody responses after rVSVΔG-ZEBOV-GP and Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccines: a modelling study from the PREVAC randomized trial.

Valayer S, Alexandre M, Prague M, Beavogui AH, Doumbia S, Kieh M, Greenwood B, Leigh B, Poupelin M, Schwimmer C, Sow SO, Berry IM, Kuhn JH, Fusco D, Cauwelaert ND, Watson-Jones D, Thiébaut R, Lévy Y, Yazdanpanah Y, Richert L, Lhomme E, ,Aboulhab J, Aguirre-MacKenzie M, Akoo P, Akpa E, Akpata R, Albert S, Ale BM, Alimamy-Bangura S, Andong P, Andrews BC, Anoma S, Atri N, Augier A, Awuondo K, Ayouba A, Badio M, Bagayoko A, Balde A, Balssa J, Bangura LM, Barrington K, Barte de Saint Fare E, Baseler B, Bauder A, Bauduin C, Bawo L, Beavogui AH, Belson M, Ben-Farhat S, Bererd M, Bernaud N, Beyslow T, Biai N, Billioux J, Billouin-Frazier S, Binachon B, Blie J, Bockstal V, Boison P, Bolay F, Boly A, Bonawitz RE, Borg AG, Bosompem S, Bozman C, Brady T, Browne S, Bullis R, Cagniard B, Cahill K, Cai Y, Camara AA, Camara AK, Camara AM, Campagne A, Campion C, Cantan A, Cash J, Chai SP, Chambelin F, Chea M, Chêne G, Choi E, Chouinard M, Chung F, Chung L, Ciancia S, Cisse PN, Cline-Cole E, Colin C, Coller BA, Conde DS, Cone K, Cone K, Connor L, Connor N, Cooper JB, Couffin-Cardiergues S, Coulibaly F, Coulibaly M, Crew P, Dabakuyo-Yonli S, Dabitao D, Damerval T, Davis B, Deen GF, Dekeyster E, Delfraissy JF, Delmas C, Diakite M, Diallo A, Diallo FA, Diallo MS, Diarra A, Diarra S, Diawara O, Dighero-Kemp B, Diop S, Diouf W, Dixit S, Djenabou B, Doepel L, D’Ortenzio E, Doumbia S, Doumbia MM, Douoguih M, Dozier N, Cauwelaert ND, DuChêne A, Duvenhage M, Eckes R, Elliott E, Enria L, Espérou H, Etienne C, Eyler A, Fakoli L, Fallah M, Fauvel MA, Faye S, Fayiah J, Fleck S, Fofana V, Tchos KF, Franklin K, Fusco D, Gaddah A, Gaignet M, Gallagher K, Gardner J, Gichini H, Gozalbes JG, Grandits G, Gray M, Greenwood B, Grobler N, Gross R, Grue L, Grund B, Guindo O, Gupta S, Haidara F, Hamz B, Hancox E, Hébert JC, Hendriks J, Hensley P, Hensley LE, Herpin B, Higgs E, Hilton T, Hneino M, Höeltermann TA, Holley HP, Hoover M, Howard N, Hughes M, Ilo D, Irvine S, Ishola D, Jato Y, Joe M, Johnson M, Kaba AS, Kagan J, Kallon K, Kamara M, Kante M, Katoudi J, Keita CM, Keita S, Keita S, Kennedy SB, Keshinro B, Kiawu H, Kieh M, Killinger B, Kinda M, Kirchoff M, Kocher G, Kodio M, Kohn B, Koivogui L, Kojan R, Koli CF, Koli JS, Kollie D, Kopka S, Koroma B, Kowuor D, Kpayieli-Freeman C, Kwast L, Lacabaratz C, Lacarra B, Lambert L, Lambeth C, Lancrey-javal S, Lane HC, Langba S, Lawal B, Lee AW, Lee S, Lees S, Lefevre A, Leigh B, Lemarcis F, Lévy Y, Levy-Marchal C, Leyssen M, Lhomme E, Liang J, Linga M, Liu K, Lowe B, Lysander J, Mahamadou I, Maljkovic-Berry I, Mambiah M, Manno D, Marchand J, Marron L, Massaquoi MB, Masson L, Matard C, Mazur S, McCullough J, McFadyen K, McLean C, Mercier N, Michavila P, Miller T, Millimouno NP, Miranda A, Mohamed S, Mooney T, Muamba D, Mulbah J, Ndamenyaa RL, Neaton J, Neboua D, Nelson M, Newell K, Nguyen VK, Njie Y, Njoh W, Novotney-Barry A, Onorato M, Onwuchekwa U, Orsega S, Ortega-Perez I, Osborne C, Otieno T, Oulaï D, Patel S, Peart D, Peeters M, Pettitt J, Peiffer-Smadja N, Phillips R, Pierson J, Piot P, Piziali M, Pong S, Postnikova E, Proffitt C, Quach A, Quigley S, Randunu N, Richert L, Rivière P, Robinson C, Roy C, Russell AF, Sahr P, Saliba K, Samai M, Samake S, Sandrus J, Sanogo I, Sarro YS, Sawadogo S, Sayadi S, Schvartz M, Schwimmer C, Secka F, Sharma H, Shelley D, Shobayo B, Siddiqui S, Simon J, Simpson S, Sivahera BM, Slater K, Smolskis M, Smout E, Snowden E, Soutthiphong AA, Sow A, Sow SO, Sow Y, Stirratt M, Stoop J, Subramaniam G, Surugue L, Swales N, Tamba S, Tang C, Tangara C, Tapia MD, Teahton J, Tegli J, Termote M, Thaurignac G, Thiebaut R, Thompson G, Tierney J, Tindanbil D, Tour A, Towalid E, Traina S, Traore A, Tyee T, Vallée D, Vatrinet R, Vincent C, Vogel S, Wallet C, Warren T, Watson-Jones D, Weaver W, Wentworth D, Wesseh C, Whitworth H, Whitworth J, Wiedemann A, Willems W, Wilson B, Wolf J, Wurie A, Yamadjako D, Yaradouno M, Yarmie Q, Yazdanpanah Y, Yu S, Zeggani Z, Zhou H

Emerg Microbes Infect. 2025 12;14(1):2432353

Are older women with early-stage endometrial cancer undertreated and more likely to die from their cancer?

Barben J, Kamga AM, Guilloteau A, Quipourt V, Bengrine-Lefevre L, Dabakuyo-Yonli TS

Maturitas. 2025 09 27;202:108741

Characteristics, management and factors associated with poor outcomes in COVID-19 patients in Burkina Faso: insights from a 2021 large-scale ambispective study.

Mamguem Kamga A, Ouédraogo S, Kaboré FN, Traoré IT, Ouédraogo E, Poda A, Diendéré AE, Kania D, Badolo H, Sanou G, Koné A, Kagoné TS, Konaté B, Médah R, de Rekeneire N, Ouédraogo B, Billa O, Paradis G, Tinto H, Dabakuyo-Yonli TS

Front Public Health. 2025 07 10;13:1542024

Advanced Epithelial Ovarian Cancer: Have We Really Improved Care for Patients Aged 70 Years and Older? A 20-year Registry-based Study.

Barben J, Mamguem Kamga A, Quipourt V, Marilier S, Niogret J, Bengrine-Lefevre L, Dabakuyo-Yonli TS

Clin Oncol (R Coll Radiol). 2025 05 10;43:103860

Impact of lenalidomide consolidation on health-related quality of life in chronic lymphocytic leukemia: ancillary study of the phase III CLL6-RESIDUUM trial.

Wasse SK, Dabakuyo-Yonli ST, Gottlieb D, Cymbalista F, Mulligan S, Maynadie M, Aurran-Schleinitz T

BMC Cancer. 2025 04 16;25(1):712

Prevalence, clinicopathologic features and long-term overall survival of early breast cancer patients eligible for adjuvant abemaciclib and/or ribociclib.

Ladoire S, Kamga AM, Galland L, Reda M, Desmoulins I, Mayeur D, Kaderbhai C, Ilie S, Hennequin A, Talucier H, Jankowski C, Coutant C, Arnould L, Dabakuyo S

NPJ Breast Cancer. 2025 02 1;11(1):10

The challenge of ovarian cancer care in the oldest old.

Barben J, Galvin A, Kamga AM, Bertrand N, Niogret J, Tisserand J, Quipourt V, Bengrine-Lefevre L, Dabakuyo-Yonli TS

Cancer Epidemiol. 2024 11 5;:102697

Fostering patients' participation in oncology research by developing psychological empowerment and a sense of community.

Bauquier C, Pannard M, Andrin A, Biaudet J, Parnalland S, Dabakuyo S, Guillemin F, Paret G, Jacob G, Préau M,

J Epidemiol Popul Health. 2024 10 30;72(6):202781

Impact of organized and opportunistic screening on excess mortality and on social inequalities in breast cancer survival.

Poiseuil M, Molinié F, Dabakuyo-Yonli TS, Laville I, Fauvernier M, Remontet L, Amadeo B, Coureau G

Int J Cancer. 2024 09 7;:

Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.

Ladoire S, Mamguem Kamga A, Galland L, Desmoulins I, Mayeur D, Kaderbhai C, Ilie SM, Hennequin A, Jankowski C, Albuisson J, Nambot S, Coutant C, Arnould L, Reda M, Truntzer C, Dabakuyo S

Breast. 2024 08 28;78:103789

Access to primary care and mortality in excess for patients with cancer in France: Results from 21 French Cancer Registries.

Gardy J, Wilson S, Guizard AV, Bouvier V, Launay L, Alves A, Bara S, Bouvier AM, Coureau G, Cowppli-Bony A, Dabakuyo Yonli S, Daubisse-Marliac L, Defossez G, Hammas K, Hure F, Jooste V, Lapotre-Ledoux B, Nousbaum JB, Plouvier S, Seigneurin A, Tretarre B, Vigneron N, Woronoff AS, Launoy G, Molinie F, Bryere J, Dejardin O

Cancer. 2024 08 20;:

Real-world effectiveness of post-trastuzumab emtansine treatment for human epidermal growth factor receptor 2-positive metastatic breast cancer: a multicenter, matched cohort analysis from the Epidemiology Strategy and Medical Economics database (2008-201

Courtinard C, Barbet V, Schiappa R, Pilleul F, Michiels S, Dabakuyo S, Gourgou S, Jaffre A, Asselain B, Bosquet L, Dunton K, Rosenlund M, Liang Z, Cathcart J, Delaloge S

ESMO Real World Data Digit Oncol. 2024 06;4:100043

Socioeconomic Deprivation and Invasive Breast Cancer Incidence by Stage at Diagnosis: A Possible Explanation to the Breast Cancer Social Paradox.

Borghi G, Delacôte C, Delacour-Billon S, Ayrault-Piault S, Dabakuyo-Yonli TS, Delafosse P, Woronoff AS, Trétarre B, Molinié F, Cowppli-Bony A

Cancers (Basel). 2024 04 27;16(9):

Evaluation of post-operative complications and adjuvant treatments following immediate prepectoral versus subpectoral direct-to-implant breast reconstruction without acellular dermal matrix.

Bassi R, Jankowski C, Dabajuyo S, Burnier P, Coutant C, Vincent L

J Plast Reconstr Aesthet Surg. 2024 04 12;95:402-410

Impact of breast surgical procedure on survival in BRCA mutated patients with invasive breast cancer: mastectomy versus conservative treatment.

Mahiou K, Jankowski C, Vincent L, Costaz H, Padeano MM, Mamguem A, Dabakuyo S, Coutant C

J Gynecol Obstet Hum Reprod. 2024 02 28;:102760

A Qualitative Study of the Experience of COVID-19 Patients in Burkina Faso.

Konaté B, Médah R, Traoré I, Ouedraogo S, Kaboré NF, Mamguem AK, Billa O, Kania D, Badolo H, Ouédraogo E, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Tinto H, Dabakuyo-Yonli TS

Am J Trop Med Hyg. 2023 12 18;:

The burden of the coronavirus disease 2019 virus infection in Burkina Faso: Results from a World Health Organization UNITY population-based, age-stratified sero-epidemiological investigation.

Ouedraogo S, Traoré IT, Kania D, Kaboré NF, Mamguem Kamga A, Badolo H, Yara M, Sanou G, Koné A, Kagoné ST, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendere AE, Ouédraogo B, Billa O, Paradis G, Tinto H, Dabakuyo-Yonli TS

Influenza Other Respir Viruses. 2023 11;17(11):e13216

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients.

Pozet A, Darnis S, Bonnet M, Meurisse A, Dabakuyo-Yonli TS, Lejeune C, Fagnoni P, Gaimard M, Manckoundia P, Quibel C, Marchand M, Anota A, Nerich V

Int J Public Health. 2023 08 30;68:1605459

Atezolizumab and paclitaxel as first line therapy in advanced triple-negative breast cancer patients included in the French early access program.

de Moura A, Vuagnat P, Renouf B, Pierga JY, Loirat D, Vaflard P, Lafayolle de la Bruyère C, Chaumard-Billotey N, Hajjaji N, Ladoire S, Dabakuyo S, Patsouris A, Frenel JS, Nicolai V, Alexandre M, Dohollou N, Grenier J, Bourien H, Bidard FC

Sci Rep. 2023 08 18;13(1):13427

Impact of Covid-19 on breast cancer stage at discovery, and time to treatment in Cote d'Or, France.

Feron Agbo C, Assogba E, Bertaut A, Mamguem Kamga A, Coutant C, Desmoulins I, Dancourt V, Sandrine Dabakuyo Yonli T

Prev Med Rep. 2023 08;34:102248

Factors Affecting Health-Related Quality of Life among Survivors of Non-Hodgkin Lymphoma: A Population-Based Study.

Wasse SK, Mounier M, Assogba E, Rossi C, Adnet J, Gauthier S, Girard S, Atsou KM, Dabakuyo-Yonli TS, Maynadie M

Cancers (Basel). 2023 07 30;15(15):

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13).

Kaboré NF, Ouédraogo S, Mamguem AK, Traoré IT, Kania D, Badolo H, Sanou G, Koné A, Yara M, Kagoné T, Ouédraogo E, Konaté B, Médah R, de Rekeneire N, Poda A, Diendéré AE, Ouédraogo B, Billa O, Paradis G, Dabakuyo-Yonli TS, Tinto H

BMC Infect Dis. 2023 06 12;23(1):394

Impact of therapeutic strategy on disease-free and overall survival of early-stage cervical cancer: Surgery alone versus preoperative radiation.

Mahiou K, Vincent L, Peignaux-Casasnovas K, Costaz H, Padeano MM, Amet A, Dabakuyo S, Mamguem Kamga A, Bengrine-Lefevre L, Coutant C

Cancer Rep (Hoboken). 2023 04 19;:e1823

Predictive value of health-related quality of life on radiotherapy-related toxicities in patients with head and neck cancer.

Billa O, Bonnetain F, Chamois J, Ligey A, Ganansia V, Renard S, Maillard S, Quivrin M, Vulquin N, Truntzer P, Noel G, Maingon P, Dabakuyo-Yonli TS

Support Care Cancer. 2023 04 14;31(5):268

Impact of complete surgical staging on survival of patients with early-stage (FIGO I or II) ovarian cancer: Data from the Cote d'Or Registry of Gynecological Cancers from 1998 to 2015.

Michel E, Mamguem Kamga A, Amet A, Padeano MM, Fumet JD, Favier L, Bengrine Lefevre L, Beltjens F, Arnould L, Dabakuyo S, Costaz H

Bull Cancer. 2023 02 17;:

Quality of life and perceived burden of the primary caregiver of patients aged 70 and over with cancer 5 years after initial treatment.

Barben J, Billa O, Collot J, Collot T, Manckoundia P, Bengrine-Lefevre L, Dabakuyo-Yonli TS, Quipourt V

Support Care Cancer. 2023 02 2;31(2):147

Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.

Licaj I, Coquan E, Dabakuyo-Yonli TS, Dauchy S, Vaz Luis I, Charles C, Lemogne C, Tredan O, Vanlemmens L, Jouannaud C, Levy C, Rigal O, Fournier M, Petit T, Dalenc F, Rouanet P, Lemonnier J, Everhard S, Cottu P, Joly F

Cancer. 2023 01 15;:

Survival after breast cancer according to participation in organised or opportunistic screening and deprivation.

Poiseuil M, Payet C, Molinié F, Dabakuyo-Yonli TS, Mathoulin-Pelissier S, Amadeo B, Coureau G

Cancer Epidemiol. 2022 12 9;82:102312

[How is our practice of mastectomy? Analysis based on population data in a French department].

Mathonnet A, Dabakuyo S, Philip CA, Jankowski C, Cortet M

Gynecol Obstet Fertil Senol. 2022 12;50(12):770-776

Prognosis of local invasive relapses after carcinoma in situ of the breast: a retrospective study from a population-based registry.

Kada Mohammed S, Dabakuyo Yonli TS, Desmoulins I, Manguem Kamga A, Jankowski C, Padeano MM, Loustalot C, Costaz H, Causeret S, Peignaux K, Rouffiac M, Coutant C, Arnould L, Ladoire S

Breast Cancer Res Treat. 2022 11 23;:

Effect of Obesity among Hospitalized Cancer Patients with or without COVID-19 on a National Level.

Cottenet J, Tapia S, Arveux P, Bernard A, Dabakuyo-Yonli TS, Quantin C

Cancers (Basel). 2022 11 17;14(22):

Cross-sectional nationwide mixed-methods population-based study of living conditions, and identification of sexual and fertility profiles among young women after breast cancer in France: the Candy study protocol.

Assogba ELF, Dumas A, Woronoff AS, Mollévi C, Coutant C, Ladoire S, Desmoulins I, Dabakuyo-Yonli TS,

BMJ Open. 2022 09 28;12(9):e056834

Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments.

Haidari RE, Anota A, Dabakuyo-Yonli TS, Guillemin F, Conroy T, Velten M, Jolly D, Causeret S, Cuisenier J, Graesslin O, Abbas LA, Nerich V

Qual Life Res. 2022 05 19;:

Cervical cancer in older women: Does age matter?

Barben J, Kamga AM, Dabakuyo-Yonli TS, Hacquin A, Putot A, Manckoundia P, Bengrine-Lefevre L, Quipourt V

Maturitas. 2022 Apr;158:40-46

To what extent do age, stage and treatment influence survival after invasive cervical cancer: a French population-based study.

Compaoré ZC, Monnet E, Gérazime A, Molinié F, Guizard AV, Delafosse P, Dabakuyo-Yonli TS, Coureau G, Hammas K, Plouvier S, Bara S, Défossez G, Lapôtre-Ledoux B, Daubisse-Marliac L, d'Almeida T, Launoy G, Mansi L, Trétarre B, Woronoff AS

Cancer Causes Control. 2022 Jan 26;:

Does baseline quality of life predict the occurrence of complications in resectable esophageal cancer?

Sheng WG, Assogba E, Billa O, Meunier B, Gagnière J, Collet D, D'Journo XB, Brigand C, Piessen G, Dabakuyo-Yonli TS

Surg Oncol. 2021 Dec 30;40:101707

How do age and social environment affect the dynamics of death hazard and survival in patients with breast or gynecological cancer in France?

Poiseuil M, Tron L, Woronoff AS, Trétarre B, Dabakuyo-Yonli TS, Fauvernier M, Roche L, Dejardin O, Molinié F, Launoy G,

Int J Cancer. 2021 Sep 14;:

Meta-analysis of randomized controlled trials and individual patient data comparing minimally invasive with open oesophagectomy for cancer.

Müller-Stich BP, Probst P, Nienhüser H, Fazeli S, Senft J, Kalkum E, Heger P, Warschkow R, Nickel F, Billeter AT, Grimminger PP, Gutschow C, Dabakuyo-Yonli TS, Piessen G, Paireder M, Schoppmann SF, van der Peet DL, Cuesta MA, van der Sluis P, van Hillegersberg R, Hölscher AH, Diener MK, Schmidt T

Br J Surg. 2021 Sep 7;:

COVID-19 epidemiological, sociological and anthropological investigation: study protocol for a multidisciplinary mixed methods research in Burkina Faso.

Traoré IT, Ouedraogo S, Kania D, Kaboré FN, Konaté B, Médah R, Badolo H, de Rekeneire N, Kamga AM, Poda A, Diendere AE, Ouédraogo B, Ouédraogo E, Billa O, Tinto H, Dabakuyo-Yonli TS

BMC Infect Dis. 2021 Sep 3;21(1):896

Randomized Trial Assessing the Impact of Routine Assessment of Health-Related Quality of Life in Patients with Head and Neck Cancer.

Billa O, Bonnetain F, Chamois J, Ligey A, Ganansia V, Noel G, Renard S, Maillard S, Quivrin M, Vulquin N, Truntzer P, Dabakuyo-Yonli TS, Maingon P

Cancers (Basel). 2021 Jul 29;13(15):

Trends in endocrine therapy prescription and survival in patients with non-metastatic hormone receptor positive breast cancer treated with endocrine therapy: A population based-study.

Mamguem Kamga A, Billa O, Ladoire S, Poillot ML, Jolimoy G, Roignot P, Coutant C, Desmoulins I, Maynadie M, Dabakuyo-Yonli TS

Breast. 2021 Jun 11;59:79-86

Five-Year Survival Outcomes of Hybrid Minimally Invasive Esophagectomy in Esophageal Cancer: Results of the MIRO Randomized Clinical Trial.

Nuytens F, Dabakuyo-Yonli TS, Meunier B, Gagnière J, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrère N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Markar SR, Piessen G,

JAMA Surg. 2021 Feb 17;:

Long-term quality of life and sexual function of elderly people with endometrial or ovarian cancer.

Mamguem Kamga A, Bengrine-Lefevre L, Quipourt V, Favier L, Darut-Jouve A, Marilier S, Arveux P, Desmoulins I, Dabakuyo-Yonli TS

Health Qual Life Outcomes. 2021 Feb 12;19(1):56

[Epidemiology of breast cancer].

Dabakuyo-Yonli S, Arveux P

Rev Prat. 2020 Sep;70(7):726-729

Survival in patients with HR+/HER2- metastatic breast cancer treated with initial endocrine therapy versus initial chemotherapy. A French population-based study.

Simon J, Chaix M, Billa O, Kamga AM, Roignot P, Ladoire S, Coutant C, Arveux P, Quantin C, Dabakuyo-Yonli TS

Br. J. Cancer. 2020 Jul 17;:

Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial.

Mamguem Kamga A, Di Martino C, Anota A, Paget-Bailly S, Coutant C, Arveux P, Desmoulins I, Dabakuyo-Yonli TS

Trials. 2020 Jun 16;21(1):527

What Are Young Women Living Conditions after Breast Cancer? Health-Related Quality of Life, Sexual and Fertility Issues, Professional Reinsertion.

Assogba ELF, Kamga AM, Costaz H, Jankowski C, Dumas A, Roignot P, Jolimoy G, Coutant C, Arveux P, Dabakuyo-Yonli TS

Cancers (Basel). 2020 Jun 12;12(6):

Socio-economic and occupational outcomes of long-term survivors of gynaecological cancer: A French population-based study.

Mamguem Kamga A, Dumas A, Joly F, Simon J, Billa O, Poillot ML, Jolimoy G, Roignot P, Coutant C, Arveux P, Dabakuyo-Yonli TS

Eur J Cancer Care (Engl). 2020 Mar 25;:e13235

Health-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial.

Mariette C, Markar S, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrere N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G,

Ann. Surg.. 2019 Aug 9;:

Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.

Lhomme E, Modet C, Augier A, Faye S, Dabakuyo-Yonli TS, Levy-Marchal C, D'Ortenzio E, Yazdanpanah Y, Chêne G, Beavogui AH, Richert L,

Trials. 2019 Jul 11;20(1):422

Prevalence of patients hospitalised for male breast cancer in France using the French nationwide hospital administrative database.

Cottenet J, Dabakuyo-Yonli TS, Mariet AS, Roussot A, Arveux P, Quantin C

Eur J Cancer Care (Engl). 2019 Jun 24;:e13117

Hybrid Minimally Invasive Esophagectomy for Esophageal Cancer.

Mariette C, Markar SR, Dabakuyo-Yonli TS, Meunier B, Pezet D, Collet D, D'Journo XB, Brigand C, Perniceni T, Carrère N, Mabrut JY, Msika S, Peschaud F, Prudhomme M, Bonnetain F, Piessen G,

N. Engl. J. Med.. 2019 01 10;380(2):152-162

Long-Term Gynecological Cancer Survivors in Côte d'Or: Health-Related Quality of Life and Living Conditions.

Mamguem Kamga A, Dumas A, Joly F, Billa O, Simon J, Poillot ML, Darut-Jouve A, Coutant C, Fumoleau P, Arveux P, Dabakuyo-Yonli TS

Oncologist. 2018 Dec 21;:

Overdiagnosis of thyroid cancer in the Marne and Ardennes Departments of France from 1975 to 2014.

Saint-Martin C, Dramé M, Dabakuyo S, Kanagaratnam L, Arveux P, Schvartz C

Ann. Endocrinol. (Paris). 2017 Feb;78(1):27-32

Breast cancer subtype of French women is not influenced by socioeconomic status: A population-based-study.

Auguste A, Cortet M, Dabakuyo-Yonli TS, Launay L, Arnould L, Desmoulins I, Roignot P, Darut-Jouve A, Poillot ML, Bertaut A, Arveux P

PLoS ONE. 2017 ;12(2):e0170069

Management of elderly patients suffering from cancer: Assessment of perceived burden and of quality of life of primary caregivers.

Germain V, Dabakuyo-Yonli TS, Marilier S, Putot A, Bengrine-Lefevre L, Arveux P, Manckoundia P, Quipourt V

J Geriatr Oncol. 2016 Dec;:

Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial.

Pozet A, Lejeune C, Bonnet M, Dabakuyo S, Dion M, Fagnoni P, Gaimard M, Imbert G, Nerich V, Foubert A, Chotard M, Bonin M, Anota A, Bonnetain F

Trials. 2016 Nov;17(1):531

Determinants of quality of life among long-term breast cancer survivors.

Chu WO, Dialla PO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, Arveux P, Dabakuyo-Yonli TS

Qual Life Res. 2016 Aug;25(8):1981-90

Prognostic value of health-related quality of life for death risk stratification in patients with unresectable glioblastoma.

Paquette B, Vernerey D, Chauffert B, Dabakuyo S, Feuvret L, Taillandier L, Frappaz D, Taillia H, Schott R, Ducray F, Fabbro M, Tennevet I, Ghiringhelli F, Guillamo JS, Durando X, Castera D, Frenay M, Campello C, Dalban C, Skrzypski J, Chinot O, Anota A, Bonnetain F

Cancer Med. 2016 Aug;5(8):1753-64

Prophylactic neck dissection for low-risk differentiated thyroid cancers: Risk-benefit analysis.

Dubernard X, Dabakuyo S, Ouedraogo S, Amroun K, Kere D, Nasser T, Deguelte S, Pochart JM, Merol JC, Makeieff M, Chays A, Schvartz C

Head Neck. 2016 Jul;38(7):1091-6

An explorative study to assess the association between health-related quality of life and the recommended phase II dose in a phase I trial: idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma.

Anota A, Boulin M, Dabakuyo-Yonli S, Hillon P, Cercueil JP, Minello A, Jouve JL, Paoletti X, Bedenne L, Guiu B, Bonnetain F

BMJ Open. 2016 Jun;6(6):e010696

Assessment of the interest of the geriatric oncology consultation among French general practitioners.

Charbonnier C, Marilier S, Dabakuyo S, Cueff A, Quipourt V, Manckoundia P

J Geriatr Oncol. 2016 Jan;7(1):47-52

Impact of age-related socio-economic and clinical determinants of quality of life among long-term breast cancer survivors.

Dialla PO, Chu WO, Roignot P, Bone-Lepinoy MC, Poillot ML, Coutant C, Arveux P, Dabakuyo-Yonli TS

Maturitas. 2015 Jul;81(3):362-70

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, A'Hern R, Bliss J, Bogaerts J, Bonnefoi H, Brain E, Cardoso MJ, Chibaudel B, Coleman R, Cufer T, Dal Lago L, Dalenc F, De Azambuja E, Debled M, Delaloge S, Filleron T, Gligorov J, Gutowski M, Jacot W, Kirkove C, MacGrogan G, Michiels S, Negreiros I, Offersen BV, Penault Llorca F, Pruneri G, Roche H, Russell NS, Schmitt F, Servent V, Thürlimann B, Untch M, van der Hage JA, van Tienhoven G, Wildiers H, Yarnold J, Bonnetain F, Mathoulin-Pélissier S, Bellera C, Dabakuyo-Yonli TS,

Ann. Oncol.. 2015 May;26(5):873-9

Idarubicin-loaded beads for chemoembolisation of hepatocellular carcinoma: results of the IDASPHERE phase I trial.

Boulin M, Hillon P, Cercueil JP, Bonnetain F, Dabakuyo S, Minello A, Jouve JL, Lepage C, Bardou M, Wendremaire M, Guerard P, Denys A, Grandvuillemin A, Chauffert B, Bedenne L, Guiu B

Aliment Pharmacol Ther. 2014 Jun;39(11):1301-13